Clover Health Investments Corp. Class A (CLOV)

Over the past six months, Clover Health's stock price has been impacted by several events. In January 2026, the company announced a 53% year-over-year membership growth in its Medicare Advantage PPO plans and expected its first full-year GAAP Net Income profitability in 2026. In February 2026, Clover Health reported its fourth-quarter and full-year 2025 results, reiterating its path to GAAP Net Income profitability, and the stock price experienced fluctuations around these earnings announcements. In March 2026, Clover Health announced a planned CFO transition but reaffirmed its full-year 2026 financial guidance. The stock has experienced general declines, with a 47.55% decrease between April 2025 and April 2026. As of April 10, 2026, the stock price was $1.93.

Demand for Clover Health's products and services exhibits seasonality, primarily driven by the Annual Election Period (AEP) for Medicare Advantage plans, which runs from October 15 to December 7 each year. During the AEP, Medicare-eligible individuals can sign up for or switch their Medicare Advantage plans, leading to a surge in membership growth. The company has consistently reported strong membership growth following the AEP.

Clover Health Investments Corp. operates in the Healthcare sector, specifically within the Healthcare Plans industry, providing Medicare Advantage insurance plans (PPO and HMO) to Medicare-eligible individuals in the U.S. Its key differentiator is the Clover Assistant, an AI-powered software platform that aids primary care physicians with patient data and insights for early detection and management of chronic diseases. Clover Health extends its technology platform through its subsidiary, Counterpart Health, Inc., offering the Counterpart Assistant to third-party payors and providers.

Clover Health manages care for Medicare beneficiaries across multiple states and plans to expand its coverage to 108 counties in eight states. In 2021, the company's service area expanded to operate in 101 new counties, bringing its total coverage for Medicare Advantage plans to 209 counties across nine states, including Alabama. States where Clover Health has a presence include Arizona, Georgia, Kansas, Mississippi, New Jersey, New York, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, and Vermont. The company's corporate headquarters are located in Franklin, Tennessee, with additional offices in San Francisco, California, Jersey City, New Jersey, and Hong Kong.

In the past year, Clover Health has focused on enhancing its brand reputation through strong performance in quality measures and membership growth. The company achieved a 4.0 Star Rating for its PPO plans for payment year 2026, and its flagship PPO plan was ranked as the number one PPO plan nationally on core HEDIS quality measures for the second year in a row as of January 2026. However, the company has also faced challenges, including a lawsuit against HHS and CMS regarding its 2026 Star Ratings.

Clover Health's ownership structure includes institutional, retail, and individual investors. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc, Geode Capital Management, Llc, State Street Corp, Charles Schwab Investment Management Inc, Renaissance Technologies Llc, PNC Financial Services Group, Inc., Dimensional Fund Advisors Lp, Susquehanna International Group, Llp, and Northern Trust Corp. Founders Vivek Garipalli and Andrew Toy retain substantial control through a dual-class share structure.